KALOBIOS PHARMACEUTICALS INC's ticker is KBIO and the CUSIP is 48344T100. A total of 35 filers reported holding KALOBIOS PHARMACEUTICALS INC in Q3 2014. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2014 | $78,000 | – | 34,089 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Opaleye Management Inc. | 545,000 | $1,474,000 | 1.09% |
| GREAT POINT PARTNERS LLC | 536,894 | $1,455,000 | 0.76% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 2,786,783 | $7,552,000 | 0.31% |
| SPHERA FUNDS MANAGEMENT LTD. | 360,000 | $976,000 | 0.22% |
| WALL STREET ASSOCIATES | 611,300 | $1,657,000 | 0.14% |
| Old West Investment Management, LLC | 57,487 | $155,000 | 0.10% |
| WEXFORD CAPITAL LP | 312,493 | $847,000 | 0.06% |
| CLOUGH CAPITAL PARTNERS L P | 402,000 | $1,089,000 | 0.03% |
| SSI INVESTMENT MANAGEMENT LLC | 73,870 | $200,000 | 0.02% |
| PRIMECAP MANAGEMENT CO/CA/ | 4,691,475 | $12,714,000 | 0.01% |